Herceptin Hylecta (Trastuzumab and hyaluronidase-oysk)

**Product type:** Human Prescription Drug

**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT); TRASTUZUMAB

**Strength:** 10000; 600 U/5mL; mg/5mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761106)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]